How mRNA Could Sharpen Flu Protection: Professor Corbett-Helaire in GBH News
Professor Kizzmekia S. Corbett-Helaire was featured in GBH News discussing Moderna’s newly approved mRNA flu vaccine and how the technology may improve influenza protection. She explains that mRNA technology presents flu proteins to the immune system with greater precision—like a high-definition image—helping the body more clearly recognize what it needs to fight.
Read the full story and her insights.
